These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8921413)

  • 1. A 125 bp region of the Ig VH1 promoter is sufficient to confer lymphocyte-specific expression in transgenic mice.
    Avitahl N; Calame K
    Int Immunol; 1996 Sep; 8(9):1359-66. PubMed ID: 8921413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the role of the 3'alpha heavy chain enhancer [3'alpha E(hs1,2)] in Vh gene somatic hypermutation.
    Tumas-Brundage KM; Vora KA; Manser T
    Mol Immunol; 1997 Apr; 34(5):367-78. PubMed ID: 9293770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the chloramphenicol acetyl transferase transgene driven by the immunoglobulin promoter and intron enhancer.
    Azuma T; Motoyama N; Fields LE; Loh DY
    Int Immunol; 1993 Feb; 5(2):121-30. PubMed ID: 8452812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermutation is observed only in antibody H chain V region transgenes that have recombined with endogenous immunoglobulin H DNA: implications for the location of cis-acting elements required for somatic mutation.
    Giusti AM; Manser T
    J Exp Med; 1993 Mar; 177(3):797-809. PubMed ID: 8436910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription.
    Shah PC; Bertolino E; Singh H
    EMBO J; 1997 Dec; 16(23):7105-17. PubMed ID: 9384588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C/EBP family of transcriptional activators is functionally important for Ig VH promoter activity in vivo and in vitro.
    Cooper C; Johnson D; Roman C; Avitahl N; Tucker P; Calame K
    J Immunol; 1992 Nov; 149(10):3225-31. PubMed ID: 1431100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features.
    Johnson TA; Rassenti LZ; Kipps TJ
    J Immunol; 1997 Jan; 158(1):235-46. PubMed ID: 8977195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the upstream boundary of somatic mutations in rearranged immunoglobulin transgenes and endogenous genes.
    Rogerson BJ
    Mol Immunol; 1994 Feb; 31(2):83-98. PubMed ID: 8309480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of immunoglobulin control elements in transgenic mice.
    Miller AE; Ennist DL; Ozato K; Westphal H
    Immunogenetics; 1992; 35(1):24-32. PubMed ID: 1729170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter: synergistic activation by CD40 ligand and IL-4 via cooperative NF-kappa B and STAT-6 binding sites.
    Schaffer A; Cerutti A; Shah S; Zan H; Casali P
    J Immunol; 1999 May; 162(9):5327-36. PubMed ID: 10228008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the imperfect octamer-containing human immunoglobulin VH6 gene promoter.
    Sun Z; Kitchingman GR
    Nucleic Acids Res; 1994 Mar; 22(5):850-60. PubMed ID: 8139927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of antigen-specific, idiotype-positive B cells in transgenic mice expressing a rearranged M167-mu heavy chain gene.
    Kenny JJ; O'Connell C; Sieckmann DG; Fischer RT; Longo DL
    J Exp Med; 1991 Nov; 174(5):1189-201. PubMed ID: 1940797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of E mu, 3'alpha (hs 1,2) and 3'kappa enhancers on mutation of an Ig-VDJ-Cgamma2a Ig heavy gene in cultured B cells.
    Lin MM; Green NS; Zhang W; Scharff MD
    Int Immunol; 1998 Aug; 10(8):1121-9. PubMed ID: 9723698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intrinsic hypermutability of antibody heavy and light chain genes decays exponentially.
    Rada C; Milstein C
    EMBO J; 2001 Aug; 20(16):4570-6. PubMed ID: 11500383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic hypermutation of Ig genes is affected differently by failures in apoptosis caused by disruption of Fas (lpr mutation) or by overexpression of Bcl-2.
    Mastache EF; Lindroth K; Fernández C; González-Fernández A
    Scand J Immunol; 2006 Jun; 63(6):420-9. PubMed ID: 16764695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of B cell development by variable gene complexity in mice reconstituted with human immunoglobulin yeast artificial chromosomes.
    Green LL; Jakobovits A
    J Exp Med; 1998 Aug; 188(3):483-95. PubMed ID: 9687526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of hypermutation in immunoglobulin heavy chain passenger transgenes.
    Johnston JM; Ihyer SR; Smith RS; Tai KF; Farmer T; Korsmeyer SJ; Nadon NL; Carroll WL
    Eur J Immunol; 1996 May; 26(5):1058-62. PubMed ID: 8647167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sequences from downstream of the J kappa cluster can combine to recruit somatic hypermutation to a heterologous, upstream mutation domain.
    Klix N; Jolly CJ; Davies SL; Brüggemann M; Williams GT; Neuberger MS
    Eur J Immunol; 1998 Jan; 28(1):317-26. PubMed ID: 9485211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Ig gene analysis reveals that monocytoid B cell lymphoma is a malignancy of mature B cells carrying somatically mutated V region genes and suggests that rearrangement of the kappa-deleting element (resulting in deletion of the Ig kappa enhancers) abolishes somatic hypermutation in the human.
    Küppers R; Hajadi M; Plank L; Rajewsky K; Hansmann ML
    Eur J Immunol; 1996 Aug; 26(8):1794-800. PubMed ID: 8765023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter-associated displacement of hypermutations.
    Wu P; Claflin L
    Int Immunol; 1998 Aug; 10(8):1131-8. PubMed ID: 9723699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.